genprowebdirectory
GEN Edge
News
Insights
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Supplement
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
Coronavirus
COVID-19 Puts Spotlight on Artificial Intelligence
Data Management
VAST Ambition When It Comes To Data Storage
Antisense
NeuBase Sets a Course for the Clinic
Gene Therapy
Cytiva Picks Up Where GE Leaves Off after $21B Deal
Coronavirus
Putting COVID-19 on the ‘Map’
News
Infectious Diseases
New Recombineering Method May Overcome Key Obstacle in Genetically Engineering Bacteria
Drug Discovery
Cocaine Cravings Curbed Dramatically in Mice Treated Using New Small Molecule
Genetics
On PAR: How X and Y Chromosomes Recombine During Meiosis
Diabetes
Electrogenetic Device Allows Remote Control of Cell Signaling
Cancer
Brain Tumor Immune Microenvironment Profiled
Insights
All
Trends for 2020
Bioprocessing
COVID-19 Will Have Long Lasting Impact on Biopharma Manufacturing
Bioprocessing
Decreasing the Time from Antibody Idea to IND Approval
Bioprocessing
Introducing New Bioprocessing Technologies in the Era of COVID-19
Bioprocessing
Smart AI Use Could Benefit Biopharma
A-Lists
Coronavirus
Blinking Red: 25 Missed Pandemic Warning Signs
Coronavirus
Vanquishing the Virus: 160+ COVID-19 Drug and Vaccine Candidates in Development
Coronavirus
Catching Up to Coronavirus: Top 60 Treatments in Development
Drug Discovery
Top 15 Best-Selling Drugs of 2019
Coronavirus
How to Conquer Coronavirus: Top 35 Treatments in Development
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Infectious Diseases
New Recombineering Method May Overcome Key Obstacle in Genetically Engineering Bacteria
Drug Discovery
Cocaine Cravings Curbed Dramatically in Mice Treated Using New Small Molecule
Diabetes
Electrogenetic Device Allows Remote Control of Cell Signaling
Cancer
Brain Tumor Immune Microenvironment Profiled
Magazine
All
Supplement
Coronavirus
Race for a Coronavirus Vaccine
Drug Discovery
Protein Modulation Helps Drug Design Get a Grip
OMICs
Proteomic Mass Spec Assesses Biomolecular Teamwork
Coronavirus
COVID-19 Drives CRISPR Diagnostics
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
On Demand Webinars
Organoids and Spheroids Help Science See in 3D
Upcoming Webinars
A CRISPR Vision for the Future of Cell Therapy
Upcoming Webinars
Looking toward the Future of Cell & Gene Therapies
Upcoming Webinars
DNA as Medicine: Encoding Cancer Therapeutic Antibodies
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Genome Editing
Gene Therapy
Gene Therapy
Gene Therapy
Synthetic Biology
CRISPR-Cas9
Featured posts
Latest
Featured posts
Most popular
7 days popular
By review score
Random
On Demand Webinars
Improving Plasmid and Viral Vectors in Cell and Gene Therapy
Gene Therapy
Gene Therapy Molecular Switch May Control Dosing
Gene Therapy
Novel Gene Therapy for Duchenne Muscular Dystrophy Shows Promise
Gene Therapy
Going Viral: The Next Generation of AAV Vectors
Gene Therapy
Gene Therapy Cures Babies with “Bubble Boy” Disease
Gene Therapy
CRISPR and Beyond: Advances in Gene Therapy
Gene Therapy
Roche Expands into Gene Therapy with Planned $4.8B Acquisition of Spark...
Gene Therapy
AbbVie, Voyager Launch $1.5B+ Gene Therapy Collaboration Aimed at Parkinson’s, Other...
Gene Therapy
Gene Therapy Restores Congenital Deafness
Gene Therapy
Wilson among Co-Founders of Gene Therapy Developer Launched with $115.5M
Gene Therapy
J&J’s Janssen to Develop MeiraGTx’s Retinal Disease Gene Therapies
Gene Therapy
In $1.9B Alliance, Neurocrine to Develop Voyager Gene Therapies for Parkinson’s,...
Gene Therapy
Nerve Regeneration Pumped Up by Muscle Protein
Gene Therapy
Orchard Therapeutics Plans 3 Approval Submissions, In-House Manufacturing by 2021
Gene Therapy
Traditional Approaches for Company Valuation Are Flawed for Valuing In Vivo...
1
2
Page 1 of 2
Scroll Up
Please wait while you are redirected to the right page...
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
![Spark Therapeutics saw its share price tumble about 30% in early-morning trading after it reported mixed preliminary data this morning from a Phase I/II trial of its hemophilia A gene therapy candidate SPK-8001. [Source: wildpixel/Getty Images]](https://www.genengnews.com/wp-content/uploads/2018/08/Dec7_2017_Getty_487489316_GeneTherapy_60019871441892139879144-265x198.jpg "Novel Gene Therapy for Duchenne Muscular Dystrophy Shows Promise")
